Molecular docking of small ligands to biologically active macromolecules has become a valuable strategy to predict the stability of complexes between potential partners and their binding modes. In this perspective, we applied this computational procedure to rationalize the reported role of polyphenols as inhibitors of the mammalian 20S proteasomes. In particular, polyphenols were shown to modulate each proteasomal activity at different extents both in the constitutive and the inducible enzyme. We performed a flexible molecular docking analysis between a set of polyphenols previously demonstrated to have the highest binding affinity and both the constitutive (from deposited PDB structures) and homology modeled active subunits of the IFN-gamma inducible proteasome, to provide insight into the possible mechanism of interaction. Among the tested polyphenols, (-)-epigallocatechin-3-gallate showed the highest affinity for the proteasome subunits, both in terms of intermolecular energy and predicted equilibrium constants, in particular for beta5 and beta5i subunits (E(total) = -66 kcal/mol, Ki = 81.3 microM and E(Total) = -83.9 kcal/mol, Ki = 0.29 microM, respectively), known to be related to the chymotrypsin-like and BrAAP activities. Collectively, polyphenols showed a higher affinity for the inducible subunits, in agreement with previous in vitro studies. Additionally, different contributions to the interaction energy (van der Waals, electrostatic, H-bond) of proteasome-polyphenols complexes were dissected.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ci800235mDOI Listing

Publication Analysis

Top Keywords

docking analysis
8
mammalian 20s
8
20s proteasomes
8
molecular docking
8
polyphenols
6
homology modeling
4
modeling docking
4
analysis interaction
4
interaction polyphenols
4
polyphenols mammalian
4

Similar Publications

Enzymatic hydrolysis approach is commonly employed for preparation of active peptides, while the limited purity and yield of produced peptides hinder further development of action mechanisms. This study presents the biotechnological approach for the efficient production of recombinant angiotensin converting enzyme (ACE) inhibitory peptide LYPVK and investigates its potential antihypertensive action mechanism. DNA encoding sequence of recombinant peptide was designed to form in tandem, which was expressed in Escherichia coli BL21 (DE3).

View Article and Find Full Text PDF

Duhuo Jisheng Mixture attenuates neuropathic pain by inhibiting S1PR1/P2YR pathway after Chronic Constriction Injury in mice.

Phytomedicine

January 2025

Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Changle West Street 15, Xi'an, Shaanxi, 710032, China. Electronic address:

Background: The pathogenesis of neuropathic pain is complex and lacks effective clinical treatment strategies. Medical plants and herbal extracts from traditional Chinese medicine with multi-target comprehensive effects have attracted great attention from scientists.

Purpose: To investigate the pharmacological active components and mechanism underlying the anti-neuralgia effect of classic analgesic formulas Duhuo Jisheng Mixture (DJM).

View Article and Find Full Text PDF

Background: Although recent progress provides mechanistic insights into diabetic nephropathy (DN), effective treatments remain scarce. DN, characterized by proteinuria and a progressive decline in renal function, primarily arises from podocyte injury, which impairs the glomerular filtration barrier. Wogonoside, a bioactive compound from the traditional Chinese herb Scutellaria baicalensis, has not been explored for its role in DN.

View Article and Find Full Text PDF

Background: Medicinal plants have historically been the cornerstone of treatment for a myriad of ailments. With modern pharmacology, many contemporary drugs have been derived from traditional medicine practices. Essential oils from these plants, known for their anti-inflammatory capabilities, have played a significant role in treating conditions such as cardiovascular and inflammatory skin diseases, as well as joint inflammation.

View Article and Find Full Text PDF

Integrated metabolomics and mass spectrometry imaging analysis reveal the efficacy and mechanism of Huangkui capsule on type 2 diabetic nephropathy.

Phytomedicine

January 2025

State key laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China; Department of Nephrology, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China. Electronic address:

Background: Huangkui capsule (HKC), a Chinese patent medicine, is clinically used for treating diabetic nephropathy. However, the core disease-specific biomarkers and targets of type 2 diabetic nephropathy (T2DN) and the therapeutic mechanism of HKC are not fully elucidated.

Purpose: This study aimed to investigate the therapeutic effects and underlying molecular mechanisms of HKC for T2DN.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!